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Abstract We have developed a mathematical model that
allows simulation of oxygen distribution in a bone defect as
a tool to explore the likely effects of local changes in cell
concentration, defect size or geometry, local oxygen
delivery with oxygen-generating biomaterials (OGBs), and
changes in the rate of oxygen consumption by cells within
a defect. Experimental data for the oxygen release rate
from an OGB and the oxygen consumption rate of a
transplanted cell population are incorporated into the
model. With these data, model simulations allow prediction
of spatiotemporal oxygen concentration within a given
defect and the sensitivity of oxygen tension to changes in
critical variables. This information may help to minimize
the number of experiments in animal models that determine
the optimal combinations of cells, scaffolds, and OGBs in
the design of current and future bone regeneration strategies. Bone marrow-derived nucleated cell data suggest that
oxygen consumption is dependent on oxygen concentration. OGB oxygen release is shown to be a time-dependent
function that must be measured for accurate simulation.
Simulations quantify the dependency of oxygen gradients
in an avascular defect on cell concentration, cell oxygen
consumption rate, OGB oxygen generation rate, and OGB
geometry.
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1 Introduction
Effective tissue regeneration in a bone defect is clinically
essential in many settings of high-energy trauma in order to
return patients to full mobility and productive life. Bone
formation requires the contribution of osteogenic (bone
forming) connective tissue progenitors (CTP-Os). CTP-Os
represent a heterogeneous population of cells resident in
bone marrow, periosteum, and other tissues that are capable
of proliferating and differentiating into one or more connective tissues [13, 14]. In many clinical settings, such as
fracture nonunion and bone defects, the local population of
CTP-Os is suboptimal [3]. In these settings, transplantation
of bone marrow-derived osteoblastic stem and progenitor
cells is a promising therapeutic strategy. However, oxygen
tension within a site where CTP-Os are transplanted is a
critical determinant of cell survival and cell fate.
CTP-Os can be readily harvested from bone and marrow
tissues. In clinical practice, they are transplanted in the
form of cancellous autograft bone or bone marrow aspirates and are often combined with biocompatible scaffolds
[2, 16]. However, the environments in which these grafts
are placed are often characterized by profound hypoxia,
which limits the likely survival of transplanted cells. As a
result, optimization of the effectiveness of such cell
transplantation in the setting of bone defects and other
tissue engineering constructs must be informed by a keen
awareness and understanding of the biological environment
into which CTP-Os and other cells are placed, particularly
with respect to hypoxia [13, 23].

In theory, the oxygen tension environment within a bone
defect can be modulated by many interacting factors,
including the vascularity of surrounding tissues, the local
concentration of cells in the defect, the rate of oxygen
consumption by cells within a defect, defect size or
geometry, and the diffusion or convection path that is
available for fuid and therefore dissolved oxygen transport
through the defect. Several studies have suggested that
oxygen tension and the outcome of tissue formation can
also be infuenced by local oxygen delivery within the
defect, using oxygen-generating biomaterials (OGBs) [1, 6,
17, 18, 24].
The goal of this project was to develop a mathematical
model to simulate oxygen distribution in an established
in vivo bone defect [15, 22] as a tool to inform and
accelerate the optimization of cell therapy strategies and
possible use of OGBs. This model is used to explore the
relative effects of variation in defect size and OGB
geometry, the number of cells, the oxygen consumption
rate of transplanted cells, and the oxygen release rate from
an OGB. This information is essential to minimize the
number of experiments in an animal model that determine
the optimal combinations of scaffold, OGB, and cell concentration, thus shortening the amount of time from bench
to bedside in developing new therapies.
Previous models have defned oxygen consumption [7–
10, 25, 28] and oxygen transport [9, 12, 14, 28] in tissues, but
these models are not designed to inform the sensitivity to
variables that may be manipulated in an established preclinical animal model to enhance clinical success. In the
following sections, we frst describe the design and development of the mathematical model, followed by experimental studies that were performed to provide objective data
on the oxygen consumption rates of the progeny of human
bone marrow-derived CTP-Os and oxygen generation rates
for gas-foamed cylinders of OGB. These experimental data
provide a clinically relevant set of parameters that enable
examination of the effect of cell number and other parameters, which are presented in subsequent sections.

2 Methods
2.1 Model development
Our general approach was to simulate the dynamic oxygen
concentration distribution in an avascular cylindrical bone
defect [15, 22]. The major components that determine the
oxygen concentration in such a defect include the surrounding vascularized tissues, the cell-seeded scaffold
implanted in the defect, and the OGBs implanted in the
center of the cell-seeded scaffold. The key model parameters relate to the defect size, scaffold size, transplanted

cell density, transplanted cell oxygen consumption rate,
and OGB oxygen release rate. Though we apply this model
to a cylindrical avascular bone defect, this model can be
modifed to apply to any defect size, transplanted cell
population, OGB, and tissue site.
A mathematical model was developed that describes mass
transport of oxygen in a cell-seeded scaffold occupying an
avascular bone defect. In the scaffold, it is assumed that the
number of cells remains constant and that the cells are distributed uniformly. Consequently, the oxygen consumption
rate is also spatially uniform. Following previous experiments [15, 20, 22, 26, 27], the annular space of the scaffold
(Fig. 1) is axially symmetric. The dominant transport process in the avascular annular space is diffusion of oxygen in
the radial direction. In the animal model simulated [15, 22],
negligible diffusion occurs axially either through the cortical
bone at the bottom of the defect or through the fxation plate
that covers the top of the defect. Convection is deemed
negligible in the absence of a vasculature and with only
minimal and irregular convection possible due to the
mechanical environment of the defect. Thus, the molar
concentration of oxygen changes according to:
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where C is the oxygen concentration (lmol ml-1), r is the
radial distance from the center of the cylinder (cm), D is a
constant diffusion coeffcient (cm2 h-1), R(C) is the
oxygen consumption rate per cell [lmol h-1
(106 cells)-1], and N is the number of cells per unit
volume in the scaffold (cells ml-1). The initial condition
assumes that the oxygen in the scaffold surrounded by the
OGB is in equilibrium with the environment:
t ¼ 0 : C ¼ Cair

ð2Þ

This is the oxygen concentration of room air
corresponding to that in an open wound at the time of
surgery. At the boundary of the scaffold and OGBs, the rate
of oxygen generation equals the rate of diffusion:
r ¼ rOGB : SD

oC
¼ VGðtÞ
or

ð3Þ

Here, S is the surface area at rOGB (cm2) and V is the
volume occupied by the OGBs (ml) so that V/S = rOGB/2.
Oxygen generation is assumed to be occurring
homogenously over the entire lateral surface area (S) of
the OGB. At the boundary of the scaffold and the
vascularized bone tissue, the oxygen is in local
equilibrium, so that its concentration is as follows:
r ¼ rbone : C ¼ Cbone

ð4Þ

The volume of the vascularized bone surrounding the
avascular defect is suffciently large relative to the volume

Fig. 1 Model geometry: a from
left to right: Photograph of
canine femoral defect creation
using a custom drill guide,
defect creation, and CTP-loaded
scaffold containing oxygengenerating biomaterials
(OGBs). b Geometry of defect.
Dark: Scaffold with CTPs.
White: OGB with no cells.
c Radial cross section of defect
in bone

of the avascular defect such that the concentration of
oxygen in the vascularized bone is assumed constant.
2.2 Oxygen generation from oxygen-generating
biomaterial (OGB)
Gas foaming was used to fabricate cylindrical OGBs
composed of poly(lactic-co-glycolic acid) (PLGA) (DURECT, Birmingham, AL) and sodium percarbonate (SPC)
(Sigma Aldrich, St. Louis, MO) using published methods
[5, 21]. The PLGA used has a lactide-to-glycolide ratio of
50:50. PLGA and SPC were ground to a size range of
106–250 lm and 1–63 lm, respectively, mixed at a mass
ratio of 70:30, placed in a 3-mm die, pressed with 1.5 tons
of pressure, and transferred to a pressure cylinder. The
composite was infused with CO2 at 800 psi and held for
20 h. Pressure was then rapidly released over 1 min causing a thermodynamic instability that fuses the PLGA particles together, encapsulating the SPC particles within the
bulk PLGA cylinder and resulting in an OGB cylinder
3 mm in diameter and 15 mm tall.
In vitro oxygen release from the OGB was measured
using fve oxygen microelectrodes (Strathkelvin Model
#1302) ftted into a RC650 respirometer (Strathkelvin
Instruments, Ltd., North Lanarkshire, Scotland). OGB
cylinders were placed in three respirometry wells, and
control cylinders fabricated with PLGA only were placed
in two separate wells. All wells were flled with sterile
water. Wells were sealed and mixed with a microstir bar to
prevent bubble formation from the oxygen-generating

reaction. All fve wells were housed within the same
temperature-controlled water bath set at 37 C to minimize
well-to-well variation in temperature fuctuation. Oxygen
concentration was measured continuously for 4 days.
Variation in data collection from electrode to electrode was
controlled by performing simultaneous calibration on all
electrodes prior to each experiment to ensure accurate
measurement. Calibration was checked at the conclusion of
data collection to ensure minimal drift of electrode signal
throughout the experiment.
The respirometry wells were opened every 12 h and
allowed to equilibrate with room air (Co = 0.341 lmol
ml-1) for the frst 48 h to prevent oxygen from accumulating to a concentration above the dynamic range of the
electrodes. The left panel of Fig. 2 shows the average
oxygen concentration hCk ðti Þi (lmol ml-1) for each 12-h
interval (ti) within each well. Data are presented for each of
three water samples containing OGB with SPC (k = 1) and
each of two water samples containing PLGA only (k = 2).
From the average oxygen concentration hCk ðti Þi
(lmol ml-1), the average oxygen accumulation, Gk, per
unit volume (lmol ml-1 h-1) of k for 12-h intervals
(ti?1 - ti, i = 0, 1, 2,…8) is:
(

Co ¼ 0:341; 0  t  48
Vwater hCk ðtiþ1 Þi  Co
;
Gk ¼
Vk
tiþ1  ti
Co ¼ hCk ðti Þi; 48  t  96


ð5Þ
where Vwater is the volume of water in the well (ml) and Vk
is the volume of k (ml). The true oxygen generation rate per
unit volume of OGBs, G (lmol ml-1 h-1), is the
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Fig. 2 Oxygen release from oxygen-generating biomaterials (OGBs).
Left: Oxygen concentration in respirometer from OGB (solid symbols)
or PLGA only (open symbols). Different symbol shapes represent data
from each individual well. Center: Oxygen release rate as a function

of time (triangles: calculated derivative of oxygen concentration
versus time data, line: piecewise ft of derivative data to three linear
segments). Right: cumulative oxygen release as a percentage of the
total oxygen released over the duration of the experiment versus time

difference between the rates of accumulation from OGB
(G1) and PLGA (G2):

54  t  75 :

GðtÞ ¼ G1  G2

ð6Þ

a ¼ 1:32  103 ½5:11  103 ; 2:47  103 
b ¼ 9:77  102 ½1:33  101 ; 3:28  101 

The center panel of Fig. 2 shows this average rate of
oxygen generation per unit volume of the OGBs for the
eight intervals and the representation of these data as a
continuous, piecewise linear function:

75  t  96 : a ¼ 5:99  105 ½3:73  105 ; 8:26  105 

GðtÞ ¼ at þ b
8
4
>
< ð5:3  10 Þ t;

Integration of G(t) over time yields the cumulative
oxygen generation (right panel). This emphasizes that more
than 90 % of the oxygen generated during the experiment
occurred in the frst 48 h.
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Piecewise linear segments were chosen as the simplest
and best model ft to the three distinct phases of oxygen
generation. The frst segment, constrained to zero to
prevent negative generation values for simulation, had a
coeffcient of determination of R2 = 0.847. Each
subsequent linear segment was constrained to the
intersection point of the previous segment to ensure a
continuous function as required for simulation. The
coeffcients of determination for these two segments were
R2 = 0.952 and 0.999, respectively. The parameters ft to
this model along with the 95 % confdence interval for
each parameter are as follows:
0  t  54 : a ¼ 5:32  104 ½3:24  104 ; 7:40  104 

b ¼ 3:77  103 ½5:69  103 ; 1:86
 103 

2.3 Tissue harvest, cell isolation, and cell culture
Discarded cancellous bone that was removed from the
proximal femur from a human patient (male, age 64)
undergoing an elective hip arthroplasty procedure was used
as the cell source in a protocol approved by the Cleveland
Clinic Institutional Review Board. Cancellous bone was
minced with an osteotome into pieces no larger than 1 mm
in any dimension and transferred to a 50-ml tube containing
10 ml of a-MEM (Sigma Aldrich, St. Louis, MO). The
sample was inverted by hand 50 times, allowed to settle, and
then inverted an additional 50 times to remove all suspended
and loosely adherent cells from the pieces of bone. The
supernatant was collected and passed through a 70-lm nylon
cell strainer (BD Biosciences, San Jose, CA) to remove bone

chips and other debris. The resultant cell fraction was centrifuged at 4009g for 10 min, and the supernatant was
removed. The pellet was resuspended in 20 ml of osteogenic
media comprising a-MEM (Sigma Aldrich, St. Louis, MO),
10 % fetal bovine serum (Cambrex, Walkersville, MD),
sodium ascorbate (50 lg ml-1) (Sigma Aldrich, St. Louis,
MO), 1 % antibiotic/antimycotic (Gibco, Grand Island, NY),
and 10-8 M dexamethasone (Sigma Aldrich, St. Louis,
MO). Twelve-millimeter glass coverslips were sterilized by
soaking in 70 % EtOH for 30 min followed by 30 min of
exposure to UV radiation. The cell suspension was diluted
accordingly and plated immediately on the coverslips at a
density of 4.42 9 105 cells cm-2. Medium was changed
twice per week, and cells were observed on a bright-feld
microscope for confuence. Coverslips were used for respirometry when a qualifed microscopist confrmed that cells
had achieved 70 % confuence.

Fig. 3 Respirometry system: a Respirometry well with oxygen
microelectrode above a confuent cell layer on a coverslip. b Fluorescent image of nuclei stained with DAPI

2.4 Cellular oxygen consumption
Closed-cell respirometry was used to measure both the
consumption of oxygen by bone marrow-derived mononuclear cells and the release of oxygen from OGBs.
Closed-cell respirometry was performed using a Strathkelvin 6 Electrode Respirometer ftted with six Strathkelvin
1302 Oxygen Electrodes with polypropylene membranes
and controlled using a Strathkelvin Model 929 6-Channel
Oxygen Meter (Warner Instruments, Hamden, CT). Each
chamber is a closed environment in which no oxygen is
allowed in or out. All measurements began at room air
(O2 = 21 % = 0.341 lmol ml-1).
To measure cell consumption, 12-mm-diameter circular
coverslips containing adherent primary bone marrowderived nucleated cells (cultured as described above) were
placed in four respirometry wells as shown in Fig. 3a. The
remaining two wells contained sterile 12-mm coverslips
without cells. All wells were flled with a-MEM (Sigma
Aldrich, St. Louis, MO) supplemented with 20 mM
HEPES (Sigma Aldrich, St. Louis, MO). Wells were
sealed, and oxygen concentration was measured until all
cell-containing wells reached \1 % oxygen. At the conclusion of the experiment, coverslips were stained for
nuclei using 40 , 6-diamidino-2-phenylindole (DAPI)
(Vector Labs, Burlingame, CA). Coverslips were then
imaged with a fuorescent microscope as seen in Fig. 3b,
and a cell count was obtained for each coverslip as previously described by Powell et al. [19] using the ColonyzeTM
analysis software. Oxygen consumption rate was calculated
as a function of oxygen concentration by taking the
derivative of the oxygen concentration as a function of
time. The oxygen consumption rate was normalized on a
per-cell basis using the cell count from each coverslip.

Fig. 4 Oxygen consumption rate of bone marrow-derived nucleated
cells: best-ft curve (black line) of saturation kinetics model to data
(diamonds) (N = 4). R2 = 0.81

The oxygen consumption rate R (lmol cell-1 h-1) of
nucleated cells derived from bone marrow is dependent on
the oxygen concentration C (lmol ml-1) in the surrounding environment (Fig. 4). The rate of oxygen consumption
increased as a function of oxygen concentration up to
0.162 lmol ml-1 and leveled off as oxygen continued to
increase. To represent the saturation kinetics of these data,
we applied a Michaelis–Menten-like model to describe
how the oxygen consumption rate varies according to our
experimental data (R2 = .704) as:
RðCÞ ¼

aC
69:2C
¼
b þ C 2:46  102 þ C

ð8Þ

The parameters ft to this model along with the 95 %
confdence interval for each parameter are as follows:
a ¼ 69:2 ½53:3; 85:1
b ¼ 2:46  102 ½1:125  104 ; 4:90  102 

3 Results
3.1 Experimental results
The OGB was shown to generate oxygen over a period of
48–60 h. Figure 2 demonstrates that over 90 % of the total
oxygen generated was released in the frst 48 h. Oxygen
accumulation was observed in chambers containing OGBs
as well as PLGA cylinders during the frst 48 h. After 48 h,
OGBs continued to accumulate oxygen, while the PLGA
cylinders ceased oxygen accumulation. This phenomenon
is likely due to the release of air trapped in the materials
during gas foaming (cylinders in both cases initially foated
to the top of the respirometry chamber). Despite any
accumulation seen in PLGA chambers, OGB chambers
generally had signifcantly higher rates of accumulation.
These data indicate that oxygen generation is occurring in
addition to the release of trapped air during the frst 48 h of
the experiment. The variability in magnitude of oxygen
generation between each OGB is likely due to the variability in the volume and distribution of trapped air. In
some instances, decreases in oxygen concentration (i.e.,
‘‘negative’’ oxygen generation or oxygen consumption)
were observed. This is likely not oxygen consumption, but
rather the result of temperature fuctuations in the water
bath, since the control wells (PLGA) always exhibited
larger decreases in oxygen than the OGB wells over the
same time intervals. To computationally defne the oxygen
generation by OGBs, the average oxygen release from
PLGA cylinders was subtracted from that of OGBs (Eq. 6).
In vivo, the combination of air trapped in the PLGA phase,
as well as chemical production of oxygen by sodium percarbonate encapsulated in OGBs (represented by G1),
would lead to even further oxygen delivery than that
reported in G(t) (Eq. 7). The dynamic range of the electrodes was limiting due to the rapid accumulation of oxygen at early time points. Though not ideal, opening of the
chambers to room air at defned intervals allowed for
continued quantifcation of oxygen accumulation by
avoiding electrode limitations.
Oxygen consumption of CTPs and their progeny
depends on oxygen concentration. Oxygen consumption of
bone marrow-derived nucleated cells varies signifcantly as
a function of oxygen tension. The data in Fig. 4 demonstrate that the oxygen consumption rate tends to increase
with oxygen tension in bone marrow-derived nucleated
cells commonly used for therapy. Similar dependency of
oxygen consumption rate on oxygen tension has been
observed in other cell populations [7, 8, 25]. Initially, these
cells consume oxygen at very low levels given the low
oxygen concentrations in the avascular defect. As oxygen
is released from the OGBs and as oxygen diffuses in from

surrounding tissues, oxygen levels rise, and Fig. 4 shows
that cells consume increasingly more oxygen until consumption rates level off at approximately 7–10 %
(0.11–0.16 lmol ml-1) of oxygen. These data suggest that
cells have the ability to regulate their consumption in order
to acclimatize to their surrounding oxygen environment.
Consequently, it is essential to include in the model the
dependence of cellular oxygen consumption rate on oxygen
concentration.
3.2 Simulation results
In addition to the empirical functions G(t) and R(C), Eqs. 7
and 8, respectively, the values of all model parameters used
for model simulation are specifed in Table 1. Since the
parameters N and a always appear as a product in this
model, the effect of these parameters on the model output
cannot be distinguished. The value for D at 37 C was
calculated using interpolation of empirical values for
oxygen in water [4]. Values of the geometric parameters
were taken from experimental studies [15, 22]. The model
involving a partial differential equation was solved
numerically using the MATLAB algorithm, ‘‘pdepe’’, to
obtain the dynamic changes in the O2 concentration distribution between an OGB placed in the center of the defect
and the bone at the periphery of the defect. Simulations
were performed to demonstrate the spatiotemporal output
of the model, as well as the sensitivity of the model to
variable parameters.
OGBs almost always exhibit a nonlinear release profle
with some degree of burst release followed by a more
stable release rate over a defned time period. Under conditions specifed in Table 2, panels A, B, and C in Fig. 5
demonstrate the change in radial distribution of oxygen
throughout the defect over 96 h corresponding to the
release rate of oxygen from OGB in the center of the defect
Table 1 Model parameters
Parameters

Description

Quantity

rOGB (cm)

Radius of oxygen-generating
biomaterial

0.15

Radius of avascular bone defect

0.5 [22]

Number of cells per unit volume
in the defect
Diffusion coeffcient of oxygen
in water at 37 C

9.31 9 105

rbone (cm)
-1

N (cells ml )
D (cm2 h-1)
Cair (lmol ml-1)

0.136 [4]

Concentration of oxygen in air

3.41 9 10-1

Cbone (lmol ml )

Concentration of oxygen in
vascularized bone tissue

5.82 9 10-2
[11]

Vwater (ml)

Volume of water in the
respirometry well

2

-1

a (unitless)

rOGB (mm)

Vwater/Vk (unitless)

Output

1

0.1

1

15

1

Fig. 5

2

0.5

1

15

1

Fig. 6a

3

0.1

1

15

1

Fig. 6a

4

0.25

1

15

1

Fig. 6a

5

0.1

5

15

1

Fig. 6b

6

0.1

1

15

1

Fig. 6b

7

0.1

0.25

15

1

Fig. 6b

8

0.1

1

7.5

1

Fig. 6c

9

0.1

1

15

1

Fig. 6c
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0.1

1

25

1

Fig. 6c
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Fig. 5 Model output as a spatiotemporal change in oxygen concentration: Under conditions specifed in Table 2, this simulation demonstrates
the effect of a time-dependent oxygen generation function (d, e, and f) on the radial distribution of oxygen in the defect over time (a, b, and c)

(D, E, and F, respectively). Oxygen levels are observed to
increase throughout the defect (A) as the OGB oxygen
release rate increases from 0 to 48 h (D). Conversely,
oxygen levels are observed to decrease (B) as the oxygen
release rate decreases from 48 to 72 h (E). Little to no
change in radial oxygen distribution is observed as the
OGB oxygen release rate remains relatively low and constant (C) from 72 to 96 h (F).
The simulation in Fig. 5 demonstrates how a timedependent oxygen generation function affects the radial
distribution of oxygen in the defect changes over time.
Consequently, the model can be used to predict the spatial
distribution of oxygen in the defect over time in

conjunction with experiments in which key parameters are
controlled. As the rate of generation, G(t), increased, a
progressively larger fraction of the defect received suffcient oxygen in areas adjacent to the OGB. Conversely, the
distribution of oxygen in the defect falls as the generation
rate decreases. The temporal changes in oxygen distribution due to OGB release are modulated by the concentration-dependent oxygen consumption. At low generation
rates (e.g., 72 h), oxygen consumption remains negligible
due to minimal oxygen accumulation so that the generation
rate still dominates. High oxygen generation rates (e.g.,
48 h) cause signifcant oxygen accumulation leading to
increased contribution of the oxygen consumption due to

4 Discussion
4.1 Simulations to quantify critical parameters
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Assumptions applied in model derivation impact the simulation results. The degree to which each assumption
affects the outcomes is important to consider. The
assumption that no cell death is occurring has perhaps the
most signifcant effect on simulation results. When oxygen
tensions drop to anoxic levels, cells are assumed to be
consuming little to no oxygen. In vivo, these cells would
likely undergo hypoxia-induced apoptosis. However, with
the assumption of no cell death, these cells are capable of
consuming oxygen at later simulation time points as oxygen returns to these formerly anoxic regions. Although
subpopulations of transplanted cells will be resistant, or
even stimulated, at low oxygen tensions, the net effect of
this assumption is likely an overestimation of cell oxygen
0.08

N = 0.5
N = 0.1
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Simulations of this model can serve as a valuable tool to
explore and understand the implications of changes in cell

concentration, consumption, and oxygen delivery in a
defned bone defect site. These data focus attention on the
critical variable of cell concentration as a principle determinant of local oxygen tension within a defect site. Based
on measured parameters of oxygen consumption and oxygen generation with our example OGB, these data suggest
that therapeutic strategies that involve the delivery of
transplanted cells at a concentration of 100,000 cells ml-1
or less may be necessary to optimize cell survival. Mathematical models are necessary to make more effcient the
task of optimizing the large number of parameters in the
design of a tissue engineering construct. A signifcant time
and cost savings can be realized through simulation of an
in vivo defect rather than through experimentation only.

O2 Concentration (umol ml )

higher oxygen concentrations. Under this condition, the
negative feedback loop of oxygen concentration-dependent
consumption prevents runaway oxygen accumulation.
The simulations in Fig. 6 illustrate the predicted sensitivity of the distribution of oxygen to changes in N (cell
concentration, (106 cells ml-1)) and a (consumption rate,
unitless), rOGB (i.e., radius (mm)), and Vwater/Vk (relative
oxygen generation rate, unitless). Parameter ranges were
selected to refect reasonable physiological and experimental values that demonstrate signifcant changes in
oxygen distribution within the defect. A parabolic-like
distribution is evident in all simulations. Analysis of the
sensitivity to cell concentration predicts that oxygen tension midway between the OGB surface and the vascularized surface of the defect would fall to near anoxic levels at
48 h unless the concentration of cells in the defect was
reduced to below 100,000 cells ml-1. A fourfold reduction
in consumption rate could also infuence oxygen tension,
but only in the setting of cell concentrations at or near
100,000 cells ml-1. Similarly, increasing oxygen generation fvefold could increase the minimum oxygen concentration signifcantly, but again, only in this critical range of
cell concentrations.
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Fig. 6 Effect of model parameters on the radial distribution of oxygen concentration: Plots represent a single time point at t = 48 h. All
simulation parameters are defned in Table 2

consumption and a possible underestimation of how few
cells need to be transplanted in order to have a fully oxygenated defect.
The assumption of no proliferation or infammatory
invasion also affects simulation results. In vivo, there is
likely some degree of proliferation and infammatory
response. By keeping the number of cells constant in
simulations, cellular consumption is likely underestimated
and the resultant prediction of oxygen levels in the defect is
likely overestimated. As indicated previously, model simulations show the greatest sensitivity to changes in cell
concentration. Overall, the assumptions of no cell death or
proliferation and no infammatory response are special
cases. If suffcient data were available, these additional
processes could also be simulated. However, the overall
effect of these cellular changes is likely more neutral since
the reduction in cells within the defect due to cell death is
offset by the addition of cells due to infammatory cells or
cell proliferation. The balance between the addition and
loss of cells will depend largely on the initial cell concentration, which would increase cell loss in the center, and
the magnitude of the infammatory response, which would
add cells to the periphery. This combination of events will
erode the assumption of a uniform distribution of cells. As
a result, the decline in actual oxygen tension at the
periphery of the defect may be steeper than predicted,
while the decline in oxygen moving away from the OGB
may be less. These effects may shift the oxygen distribution to the right.
4.3 Model fexibility for a wide variety of clinical
applications
This model incorporates defect and scaffold sizes, cellular
oxygen consumption rates, cell concentrations, neighboring
tissue oxygen concentration, and OGB production rates.
Since it accommodates so many construct design parameters, it can simulate a variety of clinically relevant situations. We chose the minimum number of parameters that
can be measured independently prior to implantation. In
order to simulate a specifc set of in vivo phenomena, these
parameters characterize the defect and the construct placed
in that defect. Simulations can minimize the time and effort
to design and fabricate a customized therapeutic populated
with the appropriate amount of cells and oxygen-generating materials for a given defect. Although this model does
not take into consideration cell proliferation and apoptosis
as variables, it is expected that their contributions are relatively small.
Based on the principles of mass transport and reaction
processes, this model can easily be adapted and applied to
other tissue types. For application to bone defects, the
model incorporates diffusion, generation, consumption,

and oxygen from surrounding tissues in a closed system.
For vascularized tissues, the model would include convection, and for an epithelial sheet of cells, oxygen consumption may not be homogenous.
4.4 Acceleration of OGB development
Simulations with this model may accelerate development
of OGBs with novel biomaterials. The data in Fig. 2
demonstrate the effcacy of OGBs in delivering oxygen
suffcient for approximately 105 cells for up to 4 days.
Previous work demonstrates the possibility of producing
oxygen in signifcant concentrations on the order of weeks
to months using similar materials [1, 5, 14, 15]. Once a
target defect and therapeutic cell population has been
selected, this model can be used to identify the benchmarks
(delivery magnitude, delivery rate, cell distribution,
geometry, etc.) necessary to create an ideal biomaterial for
the defect. This will speed development of new materials
from bench to bedside through minimization of in vitro
experiments, decreased time and cost of animal studies,
and an overall streamlined path to clinical trials.
4.5 Future studies
Model simulations can help defne the type of critical
experiments necessary for designing therapeutic OGBs and
cell-loaded constructs. The transplanted cell population
must be characterized empirically in order to determine the
rate at which cells consume oxygen and how this rate
depends on the oxygen concentration in the surrounding
environment. Then, model simulations can identify a
proper combination of OGB size and oxygen generation
rate to address a given defect and transplanted cell population. The results will serve as a benchmark for OGB
design.
4.6 Conclusions
The mathematical model developed in this study can predict the oxygen distribution for tissue regeneration in a
bone defect. This model allows systematic exploration of
the likely sensitivity of local oxygen tension to changes in
the concentration of cells transplanted, the defect size and
geometry, the rate of oxygen delivery in the defect, and the
mean oxygen consumption per cell. Simulations highlight
the critical parameter of cell concentration N in determining the oxygen concentration throughout the defect.
Although changing a has the same effect as changing N,
the value of a is an intrinsic property of the system and
cannot be externally modulated as can be done with
N. Oxygen consumption of bone marrow-derived nucleated
cells is dependent on oxygen concentration and decreases

as oxygen tension falls below 0.05 lmol ml-1. Oxygen
release from OGBs may be considered as a means of
modulation of local oxygen tension in a defect site, recognizing that oxygen release is a time-dependent function
that must be measured for accurate simulation.
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